Division Events

INFECTIOUS DISEASES GRAND ROUNDS

ROOM 131, Hanes House, 4:00 PM

 

April 2, 2018

Steve Taylor, MD

Associate Professor of Medicine

Department of Medicine

Division of Infectious Diseases

Duke University Medical Center

“Adventures in online instruction: Teaching infectious diseases epidemiology using the interweb”

April 9, 2018

Emily L. Heil, PharmD, BCPS – AQ ID, AAHIVP

Assistant Professor

Infectious Diseases

University of Maryland School of Pharmacy

Baltimore, MD

“Pharmacokinetic-Guided Antimicrobial Dosing” 

April 16, 2018

Cameron R. Wolfe, MD MBBS(Hons), MPH, FIDSA

Associate Professor of Medicine

Transplant Infectious Disease

Duke University Medical Center

April 23, 2018

Faculty Meeting

April 30, 2018

Jessica Seidelman, MD

Preeti Manavalan, MD

Department of Medicine

Division of Infectious Diseases

Duke University Medical Center

“What’s Bugging our ECMO Patients?  Infections in the ECMO Patient Population”

“Hypertension and HIV in Sub-Saharan Africa”

 

Global Learning Objectives: 
Review and discuss diagnostic and treatment plans for diseases seen in Infectious Diseases.  Discuss clinical research findings and advances in therapy as appropriate for the practice of Infectious Diseases.  Present and discuss case studies, protocols, and diagnostic and treatment guidelines as appropriate to the practice of Infectious Diseases.

Accreditation:  The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The Duke University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 credit(s)TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Unapproved Use Disclosure: Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty at this symposium may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling.  This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

RSC Activity Medical Director Disclosure: John R. Perfect, MD has indicated that he has the following professional/financial relationships to disclose relative to this activity: Honorariums, consulting and research grants – Astellas Pharma, Inc., Merck, Enzon, Schering-Plough Corp., Pfizer, Inc., Basilea, F2G,  MethylGene

There are no upcoming events at this time.